Comparison of the efficacy and tolerability of gefitinib with pemetrexed maintenance after first-line platinum-based doublet chemotherapy in advanced lung adenocarcinoma: single-center experience

PURPOSE: Both gefitinib and pemetrexed maintenance were effective therapies for advanced lung adenocarcinoma, but which is better is unclear. For patients with advanced lung adenocarcinoma, we have no idea whether we should choose gefitinib or pemetrexed maintenance in clinical practice. Here, we as...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Onco Targets Ther
Main Authors: Lin, Liping, Zhao, Juanjuan, Hu, Jiazhu, Huang, Fuxi, Han, Jianjun, He, Yan, Cao, Xiaolong
Format: Artigo
Jezik:Inglês
Izdano: Dove Medical Press 2016
Teme:
Original Research
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC5072510/
https://ncbi.nlm.nih.gov/pubmed/27789961
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/OTT.S113374
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki